Loading clinical trials...
Loading clinical trials...
EVITA is a multicentric Latin-American prospective cohort on chronic hypersensitivity pneumonitis. EVITA's objective is to identify phenotypes and/or endotypes associated with different disease trajec...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Hospital do Coracao
Collaborators
NCT06329401 · Pulmonary Fibrosis, Progressive Pulmonary Fibrosis, and more
NCT06811389 · Hypersensitivity Pneumonitis
NCT07169253 · IPF, Fibrotic Lung Disease, and more
NCT04273867 · Hypersensitivity Pneumonitis, Chronic Hypersensitivity Pneumonitis, and more
NCT04677426 · Idiopathic Pulmonary Fibrosis, Hypersensitivity Pneumonitis
Hospital Prov de Tórax Dr. A. Cetrángolo
Bueno Aires
Instituto de Rehabilitacion Psicofisica
Buenos Aires
University of Buenos Aires
Buenos Aires
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions